Glimaryl

Glimaryl

glimepiride

Manufacturer:

Hovid

Distributor:

DCH Auriga - Healthcare
Concise Prescribing Info
Contents
Glimepiride
Indications/Uses
Treatment of NIDDM, adjunct to diet & exercise.
Dosage/Direction for Use
Initially 1-2 mg once daily. Maintenance dose: 1-4 mg once daily.
Administration
Should be taken with food: Take w/ breakfast or the 1st main meal. Do not skip meals.
Contraindications
Hypersensitivity to sulfonylureas or sulfonamides. Not for type 1 DM, diabetic ketoacidosis, diabetic precoma or coma. Severe renal or hepatic impairment.
Special Precautions
Hypoglycaemia. May be associated w/ increased CV mortality. May affect ability to drive or operate machinery. Pregnancy & lactation.
Adverse Reactions
Hypoglycaemia; cold sweats, clammy skin, anxiety, tachycardia, HTN, palpitations, angina pectoris & cardiac arrhythmias; blurred vision; GI disturbances.
Drug Interactions
Enhanced hypoglycaemic effect: Insulin, other oral antidiabetics, ACE inhibitors, allopurinol, coumarin derivatives, chloramphenicol, anabolic steroids & male sex hormones, fenfluramine, disopyramide, fibrates, MAOIs, fluoxetine, guanethidine, ifosfamide, miconazole, para-aminosalicylic acid, pentoxifylline, trofosfamide, tritoqualine, tetracyclines, sulfonamides, salicylates, sulfinpyrazone, quinolones, probenecid, oxyphenbutazone, azapropazone, phenylbutazone. Reduced hypoglycaemic effect: Thyroid hormones, oestrogens & progestogens, phenothiazines, phenytoin, rifampicin, nicotinic acid, acetazolamide, barbiturates, corticosteroids, diazoxide, diuretics, adrenaline & other sympathomimetics, glucagon, laxatives. Alcohol, clonidine, reserpine, β-blockers, coumarin derivatives.
MIMS Class
ATC Classification
A10BB12 - glimepiride ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.
Presentation/Packing
Form
Glimaryl tab 2 mg
Packing/Price
30's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in